Non-invasive peripheral vascular function, incident cardiovascular disease, and mortality in the general population
- PMID: 33724298
- PMCID: PMC8859627
- DOI: 10.1093/cvr/cvab087
Non-invasive peripheral vascular function, incident cardiovascular disease, and mortality in the general population
Abstract
Aims: Evidence suggests that peripheral vascular function is related to cardiovascular disease (CVD) and mortality. We evaluated the associations of non-invasive measures of flow-mediated dilatation and peripheral arterial tonometry with incident CVD and mortality.
Methods and results: In a post-hoc analysis of the community-based Gutenberg Health Study, median age 55 years (25th/75th percentile 46/65) and 49.5% women, we measured brachial artery flow-mediated dilatation (N=12 599) and fingertip peripheral arterial tonometry (N=11 125). After a follow-up of up to 11.7 years, we observed 595 incident CVD events, 106 cardiac deaths, and 860 deaths in total. Survival curves showed decreased event-free survival with higher mean brachial artery diameter and baseline pulse amplitude and better survival with higher mean flow-mediated dilatation and peripheral arterial tonometry ratio (all Plog rank <0.05). In multivariable-adjusted Cox regression analyses only baseline pulse amplitude was inversely related to mortality [hazard ratio (HR) per standard deviation increase, 0.86, 95% confidence interval (95% CI), 0.79-0.94; P=0.0009]. After exclusion of individuals with prevalent CVD the association was no longer statistically significant in multivariable-adjusted models (HR 0.91, 95% CI 0.81-1.02; P=0.11). None of the vascular variables substantially increased the C-index of a model comprising clinical risk factors.
Conclusions: In our cohort, non-invasive measures of peripheral vascular structure and function did not reveal clinically relevant associations with incident CVD or mortality. Whether determination of pulse amplitude by peripheral arterial tonometry improves clinical decision-making in primary prevention needs to be demonstrated.
Keywords: Cohort; Epidemiology; Flow-mediated dilatation; Mortality; Non-invasive vascular function; Peripheral arterial tonometry.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
Figures



References
-
- Munzel T, Gori T, Bruno RM, Taddei S.. Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 2010;31:2741–2748. - PubMed
-
- Furchgott RF, Vanhoutte PM.. Endothelium-derived relaxing and contracting factors. Faseb J 1989;3:2007–2018. - PubMed
-
- Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, LüScher TF.. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314–1319. - PubMed
-
- Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P.. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol (1985) 2006;101:545–548. - PubMed
-
- Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr., Lehman BT, Fan S, Osypiuk E, Vita JA.. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004;109:613–619. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources